Eczema aids ‘no benefit’

ONE of the main treatments for child eczema has “no evidence of clinical benefit”, a study found.

Emollient bath additives to soften skin and ease pain cost £23million, about a third of NHS spending on the condition in children.

Tests found no difference in youngsters’ eczema when additives were used along with standard care.

Southampton University’s team said: “Research is needed into optimal regimens for leave-on emollient and soap substitutes.”